Quantitative lung T cell responses aid the rapid diagnosis of pulmonary tuberculosis

Background:The diagnosis of smear-negative pulmonary tuberculosis (TB) is problematic. There are limited data on the profile of alveolar TB antigen-specific T cells, and their utility for the rapid immunodiagnosis of pulmonary TB is unclear.Methods:Antigen-specific interferon γ (IFNγ) responses to t...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Thorax Ročník 64; číslo 10; s. 847 - 853
Hlavní autoři: Dheda, K, van Zyl-Smit, R N, Meldau, R, Meldau, S, Symons, G, Khalfey, H, Govender, N, Rosu, V, Sechi, L A, Maredza, A, Semple, P, Whitelaw, A, Wainwright, H, Badri, M, Dawson, R, Bateman, E D, Zumla, A
Médium: Journal Article
Jazyk:angličtina
Vydáno: London BMJ Publishing Group Ltd and British Thoracic Society 01.10.2009
BMJ Publishing Group
BMJ Publishing Group LTD
Témata:
ISSN:0040-6376, 1468-3296, 1468-3296
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract Background:The diagnosis of smear-negative pulmonary tuberculosis (TB) is problematic. There are limited data on the profile of alveolar TB antigen-specific T cells, and their utility for the rapid immunodiagnosis of pulmonary TB is unclear.Methods:Antigen-specific interferon γ (IFNγ) responses to the RD-1 antigens ESAT-6 and CFP-10 (T-SPOT.TB and QuantiFERON-TB-Gold-In-Tube), heparin-binding haemagglutinin and purified protein derivative were evaluated, using alveolar lavage cells, in 91 consecutively recruited South African patients suspected of having TB.Results:Of 85 evaluable patients (29% HIV+), 24, 11, 48 and 2 had definite TB, probable TB, non-TB and an uncertain diagnosis, respectively. Between 34% (T-SPOT.TB) and 41% (QuantiFERON-TB-Gold-In-Tube) of all test results were inconclusive. Failure of the positive control was significantly higher with the QuantiFERON-TB-Gold-In-Tube than with T-SPOT.TB (85% vs 46% of inconclusive results; p = 0.001). Using staphylococcal enterotoxin B, compared with phytohaemagglutinin, substantially reduced failure of the positive control (25% to 3%; p = 0.02). In evaluable samples, when the definite and non-TB groups were used for outcome analysis, the percentage sensitivity, specificity, positive predictive value and negative predictive value for T-SPOT.TB (⩾20 spots/million alveolar mononuclear cells) and QuantiFERON-TB-Gold-In-Tube (0.35 IU/ml) were 89, 94, 89 and 94% (n = 55) and 55, 86, 77 and 69% (n = 46), respectively. Rapid diagnosis of TB was achieved more frequently with T-SPOT.TB than with smear microscopy (14/24 (58%) vs. 7/24 (29%) of definite TB cases; p = 0.02). Heparin-binding haemagluttinin and purified protein derivative alveolar lymphocyte IFNγ responses had poor performance outcomes.Conclusion:Provided evaluable results are obtained, the RD-1, but not the heparin-binding haemagglutinin or purified protein derivative, alveolar lymphocyte IFNγ ELISPOT response is a useful rapid immunodiagnostic test for TB. However, test utility in high-burden settings may be limited by the high proportion of inconclusive results.
AbstractList The diagnosis of smear-negative pulmonary tuberculosis (TB) is problematic. There are limited data on the profile of alveolar TB antigen-specific T cells, and their utility for the rapid immunodiagnosis of pulmonary TB is unclear. Antigen-specific interferon gamma (IFNgamma) responses to the RD-1 antigens ESAT-6 and CFP-10 (T-SPOT.TB and QuantiFERON-TB-Gold-In-Tube), heparin-binding haemagglutinin and purified protein derivative were evaluated, using alveolar lavage cells, in 91 consecutively recruited South African patients suspected of having TB. Of 85 evaluable patients (29% HIV+), 24, 11, 48 and 2 had definite TB, probable TB, non-TB and an uncertain diagnosis, respectively. Between 34% (T-SPOT.TB) and 41% (QuantiFERON-TB-Gold-In-Tube) of all test results were inconclusive. Failure of the positive control was significantly higher with the QuantiFERON-TB-Gold-In-Tube than with T-SPOT.TB (85% vs 46% of inconclusive results; p = 0.001). Using staphylococcal enterotoxin B, compared with phytohaemagglutinin, substantially reduced failure of the positive control (25% to 3%; p = 0.02). In evaluable samples, when the definite and non-TB groups were used for outcome analysis, the percentage sensitivity, specificity, positive predictive value and negative predictive value for T-SPOT.TB (> or = 20 spots/million alveolar mononuclear cells) and QuantiFERON-TB-Gold-In-Tube (0.35 IU/ml) were 89, 94, 89 and 94% (n = 55) and 55, 86, 77 and 69% (n = 46), respectively. Rapid diagnosis of TB was achieved more frequently with T-SPOT.TB than with smear microscopy (14/24 (58%) vs. 7/24 (29%) of definite TB cases; p = 0.02). Heparin-binding haemagluttinin and purified protein derivative alveolar lymphocyte IFNgamma responses had poor performance outcomes. Provided evaluable results are obtained, the RD-1, but not the heparin-binding haemagglutinin or purified protein derivative, alveolar lymphocyte IFNgamma ELISPOT response is a useful rapid immunodiagnostic test for TB. However, test utility in high-burden settings may be limited by the high proportion of inconclusive results.
Background: The diagnosis of smear-negative pulmonary tuberculosis (TB) is problematic. There are limited data on the profile of alveolar TB antigen-specific T cells, and their utility for the rapid immunodiagnosis of pulmonary TB is unclear. Methods: Antigen-specific interferon [GAMMA] (IFN[GAMMA]) responses to the RD-1 antigens ESAT-6 and CFP-10 (T-SPOT.TB and QuantiFERON-TB-Gold-In-Tube), heparin-binding haemagglutinin and purified protein derivative were evaluated, using alveolar lavage cells, in 91 consecutively recruited South African patients suspected of having TB. Results: Of 85 evaluable patients (29% HIV+), 24, 11, 48 and 2 had definite TB, probable TB, non-TB and an uncertain diagnosis, respectively. Between 34% (T-SPOT.TB) and 41% (QuantiFERON-TB-Gold-In-Tube) of all test results were inconclusive. Failure of the positive control was significantly higher with the QuantiFERON-TB-Gold-In-Tube than with T-SPOT.TB (85% vs 46% of inconclusive results; pâ[euro]S=â[euro]S0.001). Using staphylococcal enterotoxin B, compared with phytohaemagglutinin, substantially reduced failure of the positive control (25% to 3%; pâ[euro]S=â[euro]S0.02). In evaluable samples, when the definite and non-TB groups were used for outcome analysis, the percentage sensitivity, specificity, positive predictive value and negative predictive value for T-SPOT.TB (⩾20 spots/million alveolar mononuclear cells) and QuantiFERON-TB-Gold-In-Tube (0.35 IU/ml) were 89, 94, 89 and 94% (nâ[euro]S=â[euro]S55) and 55, 86, 77 and 69% (nâ[euro]S=â[euro]S46), respectively. Rapid diagnosis of TB was achieved more frequently with T-SPOT.TB than with smear microscopy (14/24 (58%) vs. 7/24 (29%) of definite TB cases; pâ[euro]S=â[euro]S0.02). Heparin-binding haemagluttinin and purified protein derivative alveolar lymphocyte IFN[GAMMA] responses had poor performance outcomes. Conclusion: Provided evaluable results are obtained, the RD-1, but not the heparin-binding haemagglutinin or purified protein derivative, alveolar lymphocyte IFN[GAMMA] ELISPOT response is a useful rapid immunodiagnostic test for TB. However, test utility in high-burden settings may be limited by the high proportion of inconclusive results.
Background:The diagnosis of smear-negative pulmonary tuberculosis (TB) is problematic. There are limited data on the profile of alveolar TB antigen-specific T cells, and their utility for the rapid immunodiagnosis of pulmonary TB is unclear.Methods:Antigen-specific interferon γ (IFNγ) responses to the RD-1 antigens ESAT-6 and CFP-10 (T-SPOT.TB and QuantiFERON-TB-Gold-In-Tube), heparin-binding haemagglutinin and purified protein derivative were evaluated, using alveolar lavage cells, in 91 consecutively recruited South African patients suspected of having TB.Results:Of 85 evaluable patients (29% HIV+), 24, 11, 48 and 2 had definite TB, probable TB, non-TB and an uncertain diagnosis, respectively. Between 34% (T-SPOT.TB) and 41% (QuantiFERON-TB-Gold-In-Tube) of all test results were inconclusive. Failure of the positive control was significantly higher with the QuantiFERON-TB-Gold-In-Tube than with T-SPOT.TB (85% vs 46% of inconclusive results; p = 0.001). Using staphylococcal enterotoxin B, compared with phytohaemagglutinin, substantially reduced failure of the positive control (25% to 3%; p = 0.02). In evaluable samples, when the definite and non-TB groups were used for outcome analysis, the percentage sensitivity, specificity, positive predictive value and negative predictive value for T-SPOT.TB (⩾20 spots/million alveolar mononuclear cells) and QuantiFERON-TB-Gold-In-Tube (0.35 IU/ml) were 89, 94, 89 and 94% (n = 55) and 55, 86, 77 and 69% (n = 46), respectively. Rapid diagnosis of TB was achieved more frequently with T-SPOT.TB than with smear microscopy (14/24 (58%) vs. 7/24 (29%) of definite TB cases; p = 0.02). Heparin-binding haemagluttinin and purified protein derivative alveolar lymphocyte IFNγ responses had poor performance outcomes.Conclusion:Provided evaluable results are obtained, the RD-1, but not the heparin-binding haemagglutinin or purified protein derivative, alveolar lymphocyte IFNγ ELISPOT response is a useful rapid immunodiagnostic test for TB. However, test utility in high-burden settings may be limited by the high proportion of inconclusive results.
The diagnosis of smear-negative pulmonary tuberculosis (TB) is problematic. There are limited data on the profile of alveolar TB antigen-specific T cells, and their utility for the rapid immunodiagnosis of pulmonary TB is unclear.BACKGROUNDThe diagnosis of smear-negative pulmonary tuberculosis (TB) is problematic. There are limited data on the profile of alveolar TB antigen-specific T cells, and their utility for the rapid immunodiagnosis of pulmonary TB is unclear.Antigen-specific interferon gamma (IFNgamma) responses to the RD-1 antigens ESAT-6 and CFP-10 (T-SPOT.TB and QuantiFERON-TB-Gold-In-Tube), heparin-binding haemagglutinin and purified protein derivative were evaluated, using alveolar lavage cells, in 91 consecutively recruited South African patients suspected of having TB.METHODSAntigen-specific interferon gamma (IFNgamma) responses to the RD-1 antigens ESAT-6 and CFP-10 (T-SPOT.TB and QuantiFERON-TB-Gold-In-Tube), heparin-binding haemagglutinin and purified protein derivative were evaluated, using alveolar lavage cells, in 91 consecutively recruited South African patients suspected of having TB.Of 85 evaluable patients (29% HIV+), 24, 11, 48 and 2 had definite TB, probable TB, non-TB and an uncertain diagnosis, respectively. Between 34% (T-SPOT.TB) and 41% (QuantiFERON-TB-Gold-In-Tube) of all test results were inconclusive. Failure of the positive control was significantly higher with the QuantiFERON-TB-Gold-In-Tube than with T-SPOT.TB (85% vs 46% of inconclusive results; p = 0.001). Using staphylococcal enterotoxin B, compared with phytohaemagglutinin, substantially reduced failure of the positive control (25% to 3%; p = 0.02). In evaluable samples, when the definite and non-TB groups were used for outcome analysis, the percentage sensitivity, specificity, positive predictive value and negative predictive value for T-SPOT.TB (> or = 20 spots/million alveolar mononuclear cells) and QuantiFERON-TB-Gold-In-Tube (0.35 IU/ml) were 89, 94, 89 and 94% (n = 55) and 55, 86, 77 and 69% (n = 46), respectively. Rapid diagnosis of TB was achieved more frequently with T-SPOT.TB than with smear microscopy (14/24 (58%) vs. 7/24 (29%) of definite TB cases; p = 0.02). Heparin-binding haemagluttinin and purified protein derivative alveolar lymphocyte IFNgamma responses had poor performance outcomes.RESULTSOf 85 evaluable patients (29% HIV+), 24, 11, 48 and 2 had definite TB, probable TB, non-TB and an uncertain diagnosis, respectively. Between 34% (T-SPOT.TB) and 41% (QuantiFERON-TB-Gold-In-Tube) of all test results were inconclusive. Failure of the positive control was significantly higher with the QuantiFERON-TB-Gold-In-Tube than with T-SPOT.TB (85% vs 46% of inconclusive results; p = 0.001). Using staphylococcal enterotoxin B, compared with phytohaemagglutinin, substantially reduced failure of the positive control (25% to 3%; p = 0.02). In evaluable samples, when the definite and non-TB groups were used for outcome analysis, the percentage sensitivity, specificity, positive predictive value and negative predictive value for T-SPOT.TB (> or = 20 spots/million alveolar mononuclear cells) and QuantiFERON-TB-Gold-In-Tube (0.35 IU/ml) were 89, 94, 89 and 94% (n = 55) and 55, 86, 77 and 69% (n = 46), respectively. Rapid diagnosis of TB was achieved more frequently with T-SPOT.TB than with smear microscopy (14/24 (58%) vs. 7/24 (29%) of definite TB cases; p = 0.02). Heparin-binding haemagluttinin and purified protein derivative alveolar lymphocyte IFNgamma responses had poor performance outcomes.Provided evaluable results are obtained, the RD-1, but not the heparin-binding haemagglutinin or purified protein derivative, alveolar lymphocyte IFNgamma ELISPOT response is a useful rapid immunodiagnostic test for TB. However, test utility in high-burden settings may be limited by the high proportion of inconclusive results.CONCLUSIONProvided evaluable results are obtained, the RD-1, but not the heparin-binding haemagglutinin or purified protein derivative, alveolar lymphocyte IFNgamma ELISPOT response is a useful rapid immunodiagnostic test for TB. However, test utility in high-burden settings may be limited by the high proportion of inconclusive results.
Author van Zyl-Smit, R N
Maredza, A
Whitelaw, A
Semple, P
Bateman, E D
Meldau, R
Meldau, S
Dheda, K
Zumla, A
Wainwright, H
Rosu, V
Sechi, L A
Symons, G
Dawson, R
Badri, M
Khalfey, H
Govender, N
Author_xml – sequence: 1
  givenname: K
  surname: Dheda
  fullname: Dheda, K
  email: keertan.dheda@uct.ac.za
  organization: Centre for Infectious Diseases and International Health, University College Medical School, London, UK
– sequence: 2
  givenname: R N
  surname: van Zyl-Smit
  fullname: van Zyl-Smit, R N
  email: keertan.dheda@uct.ac.za
  organization: Lung Infection and Immunity Unit & CTBRI, UCT Lung Institute & Division of Pulmonology, Department of Medicine, University of Cape Town, South Africa
– sequence: 3
  givenname: R
  surname: Meldau
  fullname: Meldau, R
  email: keertan.dheda@uct.ac.za
  organization: Lung Infection and Immunity Unit & CTBRI, UCT Lung Institute & Division of Pulmonology, Department of Medicine, University of Cape Town, South Africa
– sequence: 4
  givenname: S
  surname: Meldau
  fullname: Meldau, S
  email: keertan.dheda@uct.ac.za
  organization: Lung Infection and Immunity Unit & CTBRI, UCT Lung Institute & Division of Pulmonology, Department of Medicine, University of Cape Town, South Africa
– sequence: 5
  givenname: G
  surname: Symons
  fullname: Symons, G
  email: keertan.dheda@uct.ac.za
  organization: Department of Medicine, University of Cape Town, South Africa
– sequence: 6
  givenname: H
  surname: Khalfey
  fullname: Khalfey, H
  email: keertan.dheda@uct.ac.za
  organization: Department of Medicine, University of Cape Town, South Africa
– sequence: 7
  givenname: N
  surname: Govender
  fullname: Govender, N
  email: keertan.dheda@uct.ac.za
  organization: Department of Medicine, University of Cape Town, South Africa
– sequence: 8
  givenname: V
  surname: Rosu
  fullname: Rosu, V
  email: keertan.dheda@uct.ac.za
  organization: Dipartimento di Scienze Biomediche, University of Sardinia, Sassari, Italy
– sequence: 9
  givenname: L A
  surname: Sechi
  fullname: Sechi, L A
  email: keertan.dheda@uct.ac.za
  organization: Dipartimento di Scienze Biomediche, University of Sardinia, Sassari, Italy
– sequence: 10
  givenname: A
  surname: Maredza
  fullname: Maredza, A
  email: keertan.dheda@uct.ac.za
  organization: Lung Infection and Immunity Unit & CTBRI, UCT Lung Institute & Division of Pulmonology, Department of Medicine, University of Cape Town, South Africa
– sequence: 11
  givenname: P
  surname: Semple
  fullname: Semple, P
  email: keertan.dheda@uct.ac.za
  organization: Lung Infection and Immunity Unit & CTBRI, UCT Lung Institute & Division of Pulmonology, Department of Medicine, University of Cape Town, South Africa
– sequence: 12
  givenname: A
  surname: Whitelaw
  fullname: Whitelaw, A
  email: keertan.dheda@uct.ac.za
  organization: Division of Medical Microbiology, University of Cape Town, South Africa
– sequence: 13
  givenname: H
  surname: Wainwright
  fullname: Wainwright, H
  email: keertan.dheda@uct.ac.za
  organization: Department of Anatomical Pathology, University of Cape Town, South Africa
– sequence: 14
  givenname: M
  surname: Badri
  fullname: Badri, M
  email: keertan.dheda@uct.ac.za
  organization: Department of Medicine, University of Cape Town, South Africa
– sequence: 15
  givenname: R
  surname: Dawson
  fullname: Dawson, R
  email: keertan.dheda@uct.ac.za
  organization: Lung Infection and Immunity Unit & CTBRI, UCT Lung Institute & Division of Pulmonology, Department of Medicine, University of Cape Town, South Africa
– sequence: 16
  givenname: E D
  surname: Bateman
  fullname: Bateman, E D
  email: keertan.dheda@uct.ac.za
  organization: Lung Infection and Immunity Unit & CTBRI, UCT Lung Institute & Division of Pulmonology, Department of Medicine, University of Cape Town, South Africa
– sequence: 17
  givenname: A
  surname: Zumla
  fullname: Zumla, A
  email: keertan.dheda@uct.ac.za
  organization: Centre for Infectious Diseases and International Health, University College Medical School, London, UK
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21959188$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/19592392$$D View this record in MEDLINE/PubMed
BookMark eNqFkUtv1DAUhS1URKeFNTtkCdEFUlo_YidZohHvCjRoYGs5zk3rIWMH20Htv8chQ5G6gJVf37n3XJ8TdOS8A4SeUnJOKZcX6frmnBHS5JPklXyAVrSUdcFZI4_QipCSFPP9MTqJcUcIqSmtHqFj2oiG8Yat0HYzaZds0sn-BDxM7gpvsYFhwAHi6F2EiLXtcLoGHPSYd53VV85HG7Hv8TgNe-90uMVpaiGYaZhfHqOHvR4iPDmsp-jrm9fb9bvi8vPb9-tXl0VbyioVAojoO90K09Ku5T3VALw0DTBNu1qWRvbCMMGkka1oQFaC1L0UPXBGqgY4P0VnS90x-B8TxKT2Ns7mtQM_RSUrWTFekgw-vwfu_BRc9qZoVdOaybqimXp2oKZ2D50ag93n0dSf38rAiwOgo9FDH7QzNt5xbAZpXWfuYuFM8DEG6P-WImrOTeXc1JybWnLLCnFPYX5n4l0K2g7_0BWLzsYEN3dtdPieh-eVUJ--rRXfko9k82GjvmT-5cK3-91_Tf0CylK4bw
CODEN THORA7
CitedBy_id crossref_primary_10_1016_j_ijmyco_2015_10_004
crossref_primary_10_1097_QAI_0b013e31820b07ab
crossref_primary_10_1164_rccm_201006_0963PP
crossref_primary_10_1164_rccm_201912_2425ED
crossref_primary_10_1183_09031936_00115110
crossref_primary_10_1164_ajrccm_181_3_289a
crossref_primary_10_1007_s15010_022_01789_9
crossref_primary_10_1016_j_tube_2020_101942
crossref_primary_10_1371_journal_pone_0039838
crossref_primary_10_1111_j_1440_1843_2010_01725_x
crossref_primary_10_1586_17476348_2014_852471
crossref_primary_10_5812_jjm_14030
crossref_primary_10_1111_j_1365_2796_2011_02378_x
crossref_primary_10_1164_rccm_201001_0140UP
crossref_primary_10_1016_j_ijid_2017_08_008
crossref_primary_10_1183_13993003_02189_2017
crossref_primary_10_1080_14737159_2020_1858805
crossref_primary_10_1093_infdis_jir410
crossref_primary_10_1164_rccm_201001_0083OC
crossref_primary_10_1183_09031936_00214611
crossref_primary_10_1164_rccm_201008_1246CI
crossref_primary_10_1164_rccm_200912_1931OC
crossref_primary_10_1111_tmi_12099
crossref_primary_10_1164_ajrccm_181_3_289
crossref_primary_10_1378_chest_09_2350
crossref_primary_10_5812_pedinfect_22368
crossref_primary_10_1111_j_1440_1843_2009_01692_x
crossref_primary_10_1016_j_jinf_2011_04_001
crossref_primary_10_1111_j_1440_1843_2010_01739_x
crossref_primary_10_1093_ofid_ofae496
crossref_primary_10_1097_MD_0000000000003183
crossref_primary_10_1183_09031936_00114810
crossref_primary_10_1111_j_1440_1843_2011_01941_x
crossref_primary_10_1183_09059180_00000511
crossref_primary_10_1093_infdis_jir450
crossref_primary_10_1016_j_tube_2015_10_006
crossref_primary_10_1093_infdis_jis557
crossref_primary_10_1371_journal_pone_0037436
crossref_primary_10_1016_j_diagmicrobio_2011_05_013
crossref_primary_10_1155_2013_601737
crossref_primary_10_7326_ACPJC_2018_169_8_046
crossref_primary_10_1371_journal_pone_0032482
ContentType Journal Article
Copyright BMJ Publishing Group Ltd and British Thoracic Society. All rights reserved.
2009 INIST-CNRS
Copyright: 2009 BMJ Publishing Group Ltd and British Thoracic Society. All rights reserved.
Copyright_xml – notice: BMJ Publishing Group Ltd and British Thoracic Society. All rights reserved.
– notice: 2009 INIST-CNRS
– notice: Copyright: 2009 BMJ Publishing Group Ltd and British Thoracic Society. All rights reserved.
DBID BSCLL
AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
BTHHO
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PHGZM
PHGZT
PJZUB
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOI 10.1136/thx.2009.116376
DatabaseName Istex
CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central
BMJ Journals
ProQuest One
ProQuest Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni)
Medical Database
ProQuest Central Premium
ProQuest One Academic (New)
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
ProQuest Health & Medical Research Collection
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
BMJ Journals
Health & Medical Research Collection
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
ProQuest One Academic Middle East (New)


MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1468-3296
EndPage 853
ExternalDocumentID 4027209551
19592392
21959188
10_1136_thx_2009_116376
ark_67375_NVC_3T0K0QJQ_R
thoraxjnl
Genre Evaluation Studies
Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations South Africa
Cape Town South Africa
GeographicLocations_xml – name: South Africa
– name: Cape Town South Africa
GroupedDBID ---
.55
.GJ
.VT
08G
0R~
123
18M
29Q
2WC
354
39C
3O-
4.4
40O
53G
5RE
5VS
6PF
7X7
7~S
88E
8F7
8FI
8FJ
8R4
8R5
AAHLL
AAKAS
AAOJX
AAWJN
AAWTL
AAYEP
ABAAH
ABJNI
ABKDF
ABMQD
ABOCM
ABTFR
ABUWG
ABVAJ
ACGFO
ACGFS
ACGTL
ACHTP
ACMFJ
ACOAB
ACOFX
ACQSR
ACTZY
ADBBV
ADCEG
ADZCM
AENEX
AFKRA
AFWFF
AGQPQ
AHMBA
AHNKE
AHQMW
AJYBZ
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ASPBG
AVWKF
AZFZN
BAWUL
BENPR
BLJBA
BOMFT
BPHCQ
BTFSW
BTHHO
BVXVI
C45
CAG
CCPQU
COF
CS3
CXRWF
DIK
DU5
E3Z
EBS
EJD
F5P
FEDTE
FYUFA
GX1
H13
HAJ
HMCUK
HVGLF
HYE
HZ~
IAO
IEA
IH2
IHR
IOF
ITC
J5H
KQ8
L7B
M1P
N4W
N9A
NTWIH
NXWIF
O9-
OK1
OVD
P2P
PHGZT
PQQKQ
PROAC
PSQYO
Q2X
R53
RHI
RMJ
RPM
RV8
TEORI
TR2
UAW
UKHRP
UYXKK
V24
VM9
VVN
W8F
WH7
X7M
YFH
YOC
YQY
ZCG
ZGI
3V.
BSCLL
RHF
AAYXX
ACQHZ
AERUA
AFFHD
CITATION
PHGZM
PJZUB
PPXIY
ADGHP
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
ID FETCH-LOGICAL-b467t-5e05fdab5cb1db3f1aee34c9e2a1d864c6f5c2526c6b59e67508f65fe32079e33
IEDL.DBID BENPR
ISICitedReferencesCount 56
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000270269700006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0040-6376
1468-3296
IngestDate Sun Nov 09 13:24:44 EST 2025
Tue Oct 07 06:48:40 EDT 2025
Mon Jul 21 06:04:23 EDT 2025
Mon Jul 21 09:14:48 EDT 2025
Tue Nov 18 22:40:33 EST 2025
Sat Nov 29 03:47:22 EST 2025
Wed Oct 30 09:41:01 EDT 2024
Thu Apr 24 23:05:36 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords Lung disease
Respiratory disease
Lung
Pulmonary tuberculosis
Cellular immunity
Mycobacterial infection
Infection
Bacteriosis
Anesthesia
Circulatory system
Diagnosis
Cardiology
Quantitative analysis
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-b467t-5e05fdab5cb1db3f1aee34c9e2a1d864c6f5c2526c6b59e67508f65fe32079e33
Notes istex:F179394F03BEE78B15C40DFE7F98E18B3321BB50
href:thoraxjnl-64-847.pdf
local:thoraxjnl;64/10/847
PMID:19592392
ark:/67375/NVC-3T0K0QJQ-R
ArticleID:tx116376
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Undefined-1
ObjectType-Feature-3
content type line 23
OpenAccessLink https://thorax.bmj.com/content/thoraxjnl/64/10/847.full.pdf
PMID 19592392
PQID 1781826871
PQPubID 2041050
PageCount 7
ParticipantIDs proquest_miscellaneous_67672340
proquest_journals_1781826871
pubmed_primary_19592392
pascalfrancis_primary_21959188
crossref_primary_10_1136_thx_2009_116376
crossref_citationtrail_10_1136_thx_2009_116376
istex_primary_ark_67375_NVC_3T0K0QJQ_R
bmj_primary_10_1136_thx_2009_116376
PublicationCentury 2000
PublicationDate 2009-10-01
PublicationDateYYYYMMDD 2009-10-01
PublicationDate_xml – month: 10
  year: 2009
  text: 2009-10-01
  day: 01
PublicationDecade 2000
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Thorax
PublicationTitleAlternate Thorax
PublicationYear 2009
Publisher BMJ Publishing Group Ltd and British Thoracic Society
BMJ Publishing Group
BMJ Publishing Group LTD
Publisher_xml – name: BMJ Publishing Group Ltd and British Thoracic Society
– name: BMJ Publishing Group
– name: BMJ Publishing Group LTD
References Hougardy, Schepers, Place 2007; 2
Bossuyt, Reitsma, Bruns 2003; 49
Pai, Zwerling, Menzies 2008; 149
Dheda, Chang, Breen 2005; 172
Delogu, Bua, Pusceddu 2004; 239
Delogu, Sanguinetti, Posteraro 2006; 74
Zanetti, Bua, Delogu 2005; 12
Silver, Zukowski, Kotake 2003; 29
Ling, Flores, Riley 2008; 3
Pai, Dheda, Cunningham 2007; 7
Ribeiro-Rodrigues, Resende, Johnson 2002; 9
Barry, Lipman, Bannister 2003; 187
Gerosa, Nisii, Righetti 1999; 92
Temmerman, Pethe, Parra 2004; 10
Dheda, Chang, Breen 2005; 19
Breen, Barry, Smith 2008; 63
Robinson, Ying, Taylor 1994; 149
Guyot-Revol, Innes, Hackforth 2006; 173
Jafari, Ernst, Strassburg 2008; 31
Dheda, Udwadia, Huggett 2005; 11
Sable, Goyal, Verma 2007; 29
Condos, Rom, Liu 1998; 157
Locht, Hougardy, Rouanet 2006; 86
Hougardy, Place, Hildebrand 2007; 176
Wilkinson, Wilkinson, Pathan 2005; 40
Ortbals, Marr 1978; 117
Mazurek, Weis, Moonan 2007; 45
Nemeth, Winkler, Zwick 2009; 265
Jafari, Ernst, Kalsdorf 2006; 174
20805186 - Thorax. 2010 Sep;65(9):842; author reply 842-3
References_xml – volume: 149
  start-page: 989
  year: 1994
  article-title: Evidence for a Th1-like bronchoalveolar T-cell subset and predominance of interferon-gamma gene activation in pulmonary tuberculosis.
  publication-title: Am J Respir Crit Care Med
– volume: 45
  start-page: 837
  year: 2007
  article-title: Prospective comparison of the tuberculin skin test and 2 whole-blood interferon-gamma release assays in persons with suspected tuberculosis.
  publication-title: Clin Infect Dis
– volume: 29
  start-page: 117
  year: 2003
  article-title: Recruitment of antigen-specific Th1-like responses to the human lung following bronchoscopic segmental challenge with purified protein derivative of mycobacterium tuberculosis.
  publication-title: Am J Respir Cell Mol Biol
– volume: 172
  start-page: 501
  year: 2005
  article-title: In vivo and in vitro studies of a novel cytokine, interleukin-4delta2, in pulmonary tuberculosis.
  publication-title: Am J Resp Crit Care Med
– volume: 63
  start-page: 67
  year: 2008
  article-title: Clinical application of a rapid lung-orientated immunoassay in individuals with possible tuberculosis.
  publication-title: Thorax
– volume: 92
  start-page: 224
  year: 1999
  article-title: CD4(+) T cell clones producing both interferon-gamma and interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients.
  publication-title: Clin Immunol
– volume: 117
  start-page: 39
  year: 1978
  article-title: A comparative study of tuberculous and other mycobacterial infections and their associations with malignancy.
  publication-title: Am Rev Respir Dis
– volume: 174
  start-page: 1048
  year: 2006
  article-title: Rapid diagnosis of smear-negative tuberculosis by bronchoalveolar lavage enzyme-linked immunospot.
  publication-title: Am J Respir Crit Care Med
– volume: 74
  start-page: 3006
  year: 2006
  article-title: The hbha gene of Mycobacterium tuberculosis is specifically upregulated in the lungs but not in the spleens of aerogenically infected mice.
  publication-title: Infect Immun
– volume: 49
  start-page: 1
  year: 2003
  article-title: Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for reporting of diagnostic accuracy.
  publication-title: Clin Chem
– volume: 173
  start-page: 803
  year: 2006
  article-title: Regulatory T cells are expanded in blood and disease sites in tuberculosis patients.
  publication-title: Am J Respir Crit Care Med
– volume: 176
  start-page: 409
  year: 2007
  article-title: Regulatory t cells depress immune responses to protective antigens in active tuberculosis.
  publication-title: Am J Respir Crit Care Med
– volume: 7
  start-page: 428
  year: 2007
  article-title: T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward.
  publication-title: Lancet Infect Dis
– volume: 31
  start-page: 261
  year: 2008
  article-title: Local immunodiagnosis of pulmonary tuberculosis by enzyme-linked immunospot.
  publication-title: Eur Respir J
– volume: 86
  start-page: 303
  year: 2006
  article-title: Heparin-binding hemagglutinin, from an extrapulmonary dissemination factor to a powerful diagnostic and protective antigen against tuberculosis.
  publication-title: Tuberculosis (Edinb)
– volume: 265
  start-page: 163
  year: 2009
  article-title: Recruitment of Mycobacterium tuberculosis specific CD4+ T cells to the site of infection for diagnosis of active tuberculosis.
  publication-title: J Intern Med
– volume: 2
  start-page: e926
  year: 2007
  article-title: Heparin-binding-hemagglutinin-induced IFN-gamma release as a diagnostic tool for latent tuberculosis.
  publication-title: PLoS ONE
– volume: 157
  start-page: 729
  year: 1998
  article-title: Local immune responses correlate with presentation and outcome in tuberculosis.
  publication-title: Am J Respir Crit Care Med
– volume: 12
  start-page: 1135
  year: 2005
  article-title: Patients with pulmonary tuberculosis develop a strong humoral response against methylated heparin-binding hemagglutinin.
  publication-title: Clin Diagn Lab Immunol
– volume: 29
  start-page: 337
  year: 2007
  article-title: Lung and blood mononuclear cell responses of tuberculosis patients to mycobacterial proteins.
  publication-title: Eur Respir J
– volume: 9
  start-page: 818
  year: 2002
  article-title: Sputum cytokine levels in patients with pulmonary tuberculosis as early markers of mycobacterial clearance.
  publication-title: Clin Diagn Lab Immunol
– volume: 239
  start-page: 33
  year: 2004
  article-title: Expression and purification of recombinant methylated HBHA in Mycobacterium smegmatis.
  publication-title: FEMS Microbiol Lett
– volume: 10
  start-page: 935
  year: 2004
  article-title: Methylation-dependent T cell immunity to Mycobacterium tuberculosis heparin-binding hemagglutinin.
  publication-title: Nat Med
– volume: 3
  start-page: e1536
  year: 2008
  article-title: Commercial nucleic-acid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: meta-analysis and meta-regression.
  publication-title: PLoS ONE
– volume: 11
  start-page: 195
  year: 2005
  article-title: Utility of the antigen-specific interferon-gamma assay for the management of tuberculosis.
  publication-title: Curr Opin Pulm Med
– volume: 187
  start-page: 243
  year: 2003
  article-title: Purified protein derivative-activated type 1 cytokine-producing CD4+ T lymphocytes in the lung: a characteristic feature of active pulmonary and nonpulmonary tuberculosis.
  publication-title: J Infect Dis
– volume: 19
  start-page: 1601
  year: 2005
  article-title: Expression of a novel cytokine, IL-4delta2, in HIV and HIV–tuberculosis co-infection.
  publication-title: AIDS
– volume: 149
  start-page: 177
  year: 2008
  article-title: Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update.
  publication-title: Ann Intern Med
– volume: 40
  start-page: 184
  year: 2005
  article-title: Ex vivo characterization of early secretory antigenic target 6-specific t cells at sites of active disease in pleural tuberculosis.
  publication-title: Clin Infect Dis
– reference: 20805186 - Thorax. 2010 Sep;65(9):842; author reply 842-3
SSID ssj0008117
Score 2.2010577
Snippet Background:The diagnosis of smear-negative pulmonary tuberculosis (TB) is problematic. There are limited data on the profile of alveolar TB antigen-specific T...
Background: The diagnosis of smear-negative pulmonary tuberculosis (TB) is problematic. There are limited data on the profile of alveolar TB antigen-specific T...
The diagnosis of smear-negative pulmonary tuberculosis (TB) is problematic. There are limited data on the profile of alveolar TB antigen-specific T cells, and...
SourceID proquest
pubmed
pascalfrancis
crossref
istex
bmj
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 847
SubjectTerms Adult
Antigens
Antigens, Bacterial - metabolism
Bacterial diseases
Bacterial diseases of the respiratory system
Bacteriological Techniques - methods
Biological and medical sciences
Biopsy
Bronchoalveolar Lavage Fluid - immunology
Cardiology. Vascular system
Drug resistance
Enzyme-Linked Immunosorbent Assay
Female
Histology
HIV
Human bacterial diseases
Human immunodeficiency virus
Humans
Infections
Infectious diseases
Interferon-gamma - metabolism
Lavage
Lymphocytes
Male
Medical sciences
Microscopy
Mycobacterium tuberculosis - immunology
Patients
Pneumology
T-Lymphocytes - immunology
Tuberculosis
Tuberculosis and atypical mycobacterial infections
Tuberculosis, Pulmonary - diagnosis
Tuberculosis, Pulmonary - immunology
Title Quantitative lung T cell responses aid the rapid diagnosis of pulmonary tuberculosis
URI https://thorax.bmj.com/content/64/10/847.full
https://api.istex.fr/ark:/67375/NVC-3T0K0QJQ-R/fulltext.pdf
https://www.ncbi.nlm.nih.gov/pubmed/19592392
https://www.proquest.com/docview/1781826871
https://www.proquest.com/docview/67672340
Volume 64
WOSCitedRecordID wos000270269700006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVPQU
  databaseName: Health & Medical Collection (Proquest)
  customDbUrl:
  eissn: 1468-3296
  dateEnd: 20250609
  omitProxy: false
  ssIdentifier: ssj0008117
  issn: 0040-6376
  databaseCode: 7X7
  dateStart: 19460301
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 1468-3296
  dateEnd: 20250609
  omitProxy: false
  ssIdentifier: ssj0008117
  issn: 0040-6376
  databaseCode: BENPR
  dateStart: 19460301
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lj9MwEB6xLUJceD8CS7EEQlyym8Sx45wQrHaFQFTbVUG9WY4folDSkgda_j3jJO1qDwsHLkkkx87js7-Z2JNvAF6iRXYC7VTovAIhsh8PC6N4KIpUxYbFNMtNl2wim07FYpGfDhNu9RBWueXEjqjNWvs58sM4E94VRv_-zeZn6LNG-dXVIYXGHoy9Ulk6gvG74-np2Y6L_W-U27g5jmNpEPeJKT9svp73cpVx7EvQthQ_vl2yTmP_os99tKSq8YW5PtPF1a5oZ5JObv_vw9yBW4MzSt72vecuXLPlPbjxaVhuvw_zWavK7i805ESyQl4gc-Kn-knVh9bamqilIehEkkpt8Mj0kXvLmqwd2bQrvJCqfpOmLWyl25UveQCfT47nR-_DIQ1DWCCLNiGzEXNGFUwXsSmoi5W1NNW5TRBNwVPNHdMJS7jmBcstfoFEwnHmLE2iLLeUPoRRuS7tYyDC5sZ4CRyr05SlDp1PgTthC8WVTlQALxAEuemFNmT3gUK5RKh8usxc9lAFcLAFSepBydwn1FhdXeH1rsI_237Vob47T1XffexbxuT0y5Gk8-hjNPswk2cBTC51i12FxMv1xEIEsL_FXg68UMsL4AN4vivGEe2xU6Vdt7X0EnoJTaMAHvW96-KeseUEHdonf2_6Kdzs1ry6kMN9GDVVa5_Bdf2rWdbVBPayRdZtxWQYLn8A7V0Y8Q
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwEB5VLQIuvB-B0lriIS6heTrOASFUqFq2XbFoQXszjuOIhSW75AHtn-I3MpNX1UPh1AOnRPLaSnY-fzOOP88APEGPnAn0U3ZGGQiR_bidpIrbIgmUm4auH8VpU2wiGo_FbBa_X4Pf_VkYklX2nNgQdbrU9I18x40EhcIY379a_bCpahTtrvYlNFpYjMzJL1yylS8P3qB9n3re3tvp7r7dVRWwEySFyg6NE2apSkKduGniZ64yxg90bDx8OMEDzbNQe6HHNU_C2GBA7YiMh5nxPSeKDX0ARcrfQB6PSEIWzYYFnkOHNnuVHseZ26UScn2-U305bpNjui61oCdLvn894ws3yKzHpM1UJZona-tqnB_4Ng5w7_r_9tfdgGtdqM1et3PjJqyZ_BZcPurEBLdhOqlV3pyxQ8ZnC2Q9NmW0kcGKVjhsSqbmKcMQmRVqhXdpq0ucl2yZsVW9wBdTxQmr6sQUul5Qyx34eCHvdBfW82Vu7gMTJk5TSvBjdBCEQYahtcCLMIniSnvKgsdodLlq04jIZvnlc4nQoGKgsWyhYcGLHhRSd3naqVzI4vwOz4cO_xz7WYOy4Xeq-EbKviiU40-70p86I2fybiI_WLB1BoZDB4-SEblCWLDZY012rFfKU6BZsD00I1-R7VRulnUpKUGg5weOBfdaNJ8-M47sYbj-4O9Db8OV_enRoTw8GI8ewtVmd68RV27CelXU5hFc0j-reVlsNZOTweeLhvQfS8J0MA
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1LbxMxEB5VCaq48H4slNYSD3FZsi97vQeEoG1ECURJFVBvxuu11ZSQhN0stH-NX8d4H6l6KJx64LQreW3ZO59nxvbnGYBnaJENRzvlGhuBELUfc9NMMpenkfQz6odxklXJJuLhkB8dJaMN-N3ehbG0ylYnVoo6Wyi7R97zY25dYfTve6ahRYz2-m-WP1ybQcqetLbpNGqIDPTZL1y-Fa8P9lDWz4Ogvz_Zfe82GQbcFBXEyqXaoyaTKVWpn6Wh8aXWYaQSHWBHOYsUM1QFNGCKpTTR6Fx73DBqdBh4caLtZiiq_26MTgbtQPfd_nB0uLYD9gpny9ljOI-bwEJ-yHqr49M6VKbv2xK0a-n3kwuWsWuFfGqZmrJAYZk6y8blbnBlDvs3_-cfeQtuNE44eVvPmtuwoed3YPNTQzO4C5NxKefV7Tu0BWSG-pBMiD3iIHlNKdYFkdOMoPNMcrnEt6xmLE4LsjBkWc5wYDI_I6sy1bkqZ7bkHny-kjHdh858MdcPgXCdZJkN_aNVFNHIoNPN8cF1KplUgXTgKQJALOsAI6JamIVMIExsmtBE1DBx4FULEKGaCO42kcjs8gov1xX-2faLCnHr72T-zXL-YiqGX3ZFOPEG3vjDWBw6sH0BkusKgQ1T5HPuwFaLO9How0Kcg86BnXUxajIrOznXi7IQNnRgEEaeAw9qZJ_3GVsOcI49-nvTO7CJSBYfD4aDx3C9OvarWJdb0FnlpX4C19TP1bTIt5uZSuDrVWP6DzCiflA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Quantitative+lung+T+cell+responses+aid+the+rapid+diagnosis+of+pulmonary+tuberculosis&rft.jtitle=Thorax&rft.au=DHEDA%2C+K&rft.au=VAN+ZYL-SMIT%2C+R.+N&rft.au=SEMPLE%2C+P&rft.au=VLLHITELAW%2C+A&rft.date=2009-10-01&rft.pub=BMJ+Publishing+Group&rft.issn=0040-6376&rft.volume=64&rft.issue=10&rft.spage=847&rft.epage=853&rft_id=info:doi/10.1136%2Fthx.2009.116376&rft.externalDBID=n%2Fa&rft.externalDocID=21959188
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0040-6376&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0040-6376&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0040-6376&client=summon